摘要
澜沧江-湄公河合作是我国与澜湄五国,即老挝、缅甸、泰国、柬埔寨、越南,共同发起和建设的新型次区域合作机制。澜沧江-湄公河次区域各国地理相近、文化相通,也孕育了各具特色的传统医药。该文通过梳理我国与其他澜湄流域国家传统医药交流的历史,以及近现代研究进展,归纳整理了当前澜沧江-湄公河次区域传统医药合作面临的挑战与机遇。在澜沧江-湄公河次区域内,多种区域合作机制长期并存,药用资源丰富但开发与利用程度各异,现代科学研究不足。澜湄合作为整合澜湄各国传统医药优势资源,携手共进提供了有力支持。该文聚焦药用资源的开发与保护,从知识产权与特色种源保护、各国通用草药典编撰、公共健康产品研发、传统药物产业基地建设等方面提出澜湄合作新路径,使传统医药能够更好地为守护民众健康,构建人类卫生健康共同体服务。
Lancang-Mekong Cooperation is a new type of subregional cooperation mechanism initiated and built by China and other five countries of the Lancang-Mekong subregion,namely Laos,Myanmar,Thailand,Cambodia,and Vietnam.Countries in the Lancang-Mekong subregion are geographically and culturally connected,and they have nurtured their unique traditional medicine.By combing the history of traditional medicine exchanges between China and other Lancang-Mekong countries and their progress of modern research,this paper summarized the challenges and opportunities of traditional medicine cooperation in the Lancang-Mekong subregion.It has been found that many regional cooperation mechanisms coexist for a long time in the Lancang-Mekong subregion and the medicinal resources are abundant.However,the degree of their development and utilization varies,and modern scientific research is insufficient.Lancang-Mekong Cooperation has provided a strong support for integrating the advantageous resources in Lancang-Mekong subregion countries and making progress together.Focusing on the development and protection of medicinal resources,this paper puts forward a new path of cooperation in the intellectual property rights and characteristic seed resource protection,the compilation of universal herbal pharmacopoeia in various countries,the research and development of public health products,and the construction of traditional herbal industry bases,thus enabling the traditional medicine to better protect the public health and building a human health community.
作者
李志勇
李皓月
张小波
张子隽
穆婧
赵元晨
宋坪
黄璐琦
LI Zhi-yong;LI Hao-yue;ZHANG Xiao-bo;ZHANG Zi-jun;MU Jing;ZHAO Yuan-chen;SONG Ping;HUANG Lu-qi(Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China;China Academy of Chinese Medical Sciences,Beijing 100700,China;National Resource Center for Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China;Academician Workstation,Jiangxi University of Traditional Chinese Medicine,Nanchang 330004,China)
出处
《中国中药杂志》
CAS
CSCD
北大核心
2021年第24期6295-6302,共8页
China Journal of Chinese Materia Medica
基金
国家中医药管理局委托办事项目。
关键词
澜沧江-湄公河合作
传统医药
药用资源
Lancang-Mekong Cooperation
traditional medicine
medicinal resources
作者简介
通信作者:宋坪,主任医师,E-mail:songping@vip.126.com;通信作者:黄璐琦,研究员,E-mail:huangluqi01@126.com。
